China Isotope & Radiation Corporation 1763.HK Stock
China Isotope & Radiation Corporation Price Chart
China Isotope & Radiation Corporation 1763.HK Financial and Trading Overview
| China Isotope & Radiation Corporation stock price | 9.71 HKD |
| Previous Close | 16.24 HKD |
| Open | 16.12 HKD |
| Bid | 16.2 HKD x 0 |
| Ask | 16.42 HKD x 0 |
| Day's Range | 16.12 - 16.5 HKD |
| 52 Week Range | 11.5 - 19.8 HKD |
| Volume | 114.4K HKD |
| Avg. Volume | 157.4K HKD |
| Market Cap | 5.19B HKD |
| Beta (5Y Monthly) | 0.829921 |
| PE Ratio (TTM) | 11.854014 |
| EPS (TTM) | 1.26 HKD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | May 25, 2022 |
| 1y Target Est | N/A |
1763.HK Valuation Measures
| Enterprise Value | 5.22B HKD |
| Trailing P/E | 11.854014 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.8452041 |
| Price/Book (mrq) | 1.1634071 |
| Enterprise Value/Revenue | 0.849 |
| Enterprise Value/EBITDA | 4.95 |
Trading Information
China Isotope & Radiation Corporation Stock Price History
| Beta (5Y Monthly) | 0.829921 |
| 52-Week Change | -10.27% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 19.8 HKD |
| 52 Week Low | 11.5 HKD |
| 50-Day Moving Average | 16.72 HKD |
| 200-Day Moving Average | 16.03 HKD |
1763.HK Share Statistics
| Avg. Volume (3 month) | 157.4K HKD |
| Avg. Daily Volume (10-Days) | 147.86K HKD |
| Shares Outstanding | 79.97M |
| Float | 54.25M |
| Short Ratio | N/A |
| % Held by Insiders | 31.19% |
| % Held by Institutions | 21.95% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.441 |
| Trailing Annual Dividend Yield | 2.71% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.3062 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 6.37% |
| Operating Margin (ttm) | 14.21% |
| Gross Margin | 57.18% |
| EBITDA Margin | 17.15% |
Management Effectiveness
| Return on Assets (ttm) | 4.92% |
| Return on Equity (ttm) | 11.99% |
Income Statement
| Revenue (ttm) | 6.15B HKD |
| Revenue Per Share (ttm) | 19.21 HKD |
| Quarterly Revenue Growth (yoy) | 14.29% |
| Gross Profit (ttm) | N/A |
| EBITDA | 1.05B HKD |
| Net Income Avi to Common (ttm) | 391.6M HKD |
| Diluted EPS (ttm) | 1.37 |
| Quarterly Earnings Growth (yoy) | 22.50% |
Balance Sheet
| Total Cash (mrq) | 2.95B HKD |
| Total Cash Per Share (mrq) | 9.22 HKD |
| Total Debt (mrq) | 884.86M HKD |
| Total Debt/Equity (mrq) | 13.5 HKD |
| Current Ratio (mrq) | 1.884 |
| Book Value Per Share (mrq) | 13.959 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 862.66M HKD |
| Levered Free Cash Flow (ttm) | 156.88M HKD |
Profile of China Isotope & Radiation Corporation
| Country | Hong Kong |
| State | N/A |
| City | Beijing |
| Address | No. 66 Changwa Middle Street |
| ZIP | N/A |
| Phone | 86 10 6851 5220 |
| Website | https://www.china-isotope.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 3366 |
China Isotope & Radiation Corporation engages in the research and development, manufacture, and sale of diagnostic and therapeutic radiopharmaceuticals and radioactive source products for medical and industrial applications in China. It operates through five segments: Pharmaceuticals; Radioactive Source Products; Irradiation; Radiation Therapy Equipment and Related Services; and Independent Clinical Medical and Laboratory Services and Other Businesses. The Pharmaceuticals segment engages in the research, development, manufacture, and sale of imaging diagnostic and therapeutic radiopharmaceuticals; UBT kits and analyzers; and in vitro immunoassay diagnostic reagents and kits. The Radioactive Source Products segment provides medical and industrial radioactive sources products and related technical services. The Irradiation segment offers irradiation services to manufacturers of medical devices, food, traditional Chinese medicine, and cosmetics for sterilization; and EPC services for the design, manufacturing, and installation of gamma ray irradiation facilities. The Radiation Therapy Equipment and Related Services segment sells radiation therapy equipment; and provides related maintenance services. The Independent Clinical Medical and Laboratory Services and Other Businesses segment provides independent clinical laboratory services for nuclear technology industry applications and medical product applications. The company was founded in 1983 and is headquartered in Beijing, China. China Isotope & Radiation Corporation is a subsidiary of China National Nuclear Corporation.
Q&A For China Isotope & Radiation Corporation Stock
What is a current 1763.HK stock price?
China Isotope & Radiation Corporation 1763.HK stock price today per share is 9.71 HKD.
How to purchase China Isotope & Radiation Corporation stock?
You can buy 1763.HK shares on the HKSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for China Isotope & Radiation Corporation?
The stock symbol or ticker of China Isotope & Radiation Corporation is 1763.HK.
Which industry does the China Isotope & Radiation Corporation company belong to?
The China Isotope & Radiation Corporation industry is Medical Devices.
How many shares does China Isotope & Radiation Corporation have in circulation?
The max supply of China Isotope & Radiation Corporation shares is 319.88M.
What is China Isotope & Radiation Corporation Price to Earnings Ratio (PE Ratio)?
China Isotope & Radiation Corporation PE Ratio is 7.70634940 now.
What was China Isotope & Radiation Corporation earnings per share over the trailing 12 months (TTM)?
China Isotope & Radiation Corporation EPS is 1.26 HKD over the trailing 12 months.
Which sector does the China Isotope & Radiation Corporation company belong to?
The China Isotope & Radiation Corporation sector is Healthcare.